Discovery and initial validation of α 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome

Proteomics - Clinical Applications

Volumn 5, Issue 5-6, 2011, Pages 334-342

  Piyaphanee, Nuntawan ^a   Ma, Qing ^a   Kremen, Oran ^a   Czech, Kimberly ^a   Greis, Kenneth ^b   Mitsnefes, Mark ^a   Devarajan, Prasad ^a   Bennett, Michael R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Biomarker; Focal segmental glomerulosclerosis; Minimal change disease; Nephrotic syndrome; Steroid resistance

Indexed keywords

ALBUMIN; ALPHA1 GLYCOPROTEIN; BIOLOGICAL MARKER; CREATININE; STEROID;

ADULT; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; GLOMERULUS FILTRATION RATE; HUMAN; MICROALBUMINURIA; NEPHROTIC SYNDROME; NON INVASIVE MEASUREMENT; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANK SUM TEST; STATISTICAL SIGNIFICANCE; STEROID RESISTANT NEPHROTIC SYNDROME; STEROID SENSITIVE NEPHROTIC SYNDROME; STUDENT T TEST; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TREATMENT RESPONSE; UPREGULATION; URINALYSIS; VALIDATION PROCESS; WESTERN BLOTTING;

ADOLESCENT; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; MALE; NEPHROTIC SYNDROME; PEPTIDE FRAGMENTS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 79957587608     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201000110     Document Type: Article

References (33)

1. Cattran, D. C., Rao, P., Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am. J. Kidney Dis. 1998 32, 72-79.
2. Hari, P., Bagga, A., Jindal, N., Srivastava, R. N., Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr. Nephrol. 2001, 16, 901-905.
3. Gipson, D. S., Chin, H., Presler, T. P., Jennette, C. et al., Differential risk of remission and ESRD in childhood FSGS. Pediatr. Nephrol. 2006, 21, 344-349.
4. Roberti, I., Vyas, S., Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus. Pediatr. Nephrol. 2010, 25, 1117-1124.
5. Gipson, D. S., Gibson, K., Gipson, P. E., Watkins, S. et al., Therapeutic approach to FSGS in children. Pediatr. Nephrol. 2007, 22, 28-36.
6. Bonilla-Felix, M., Parra, C., Dajani, T., Ferris, M. et al., Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int. 1999, 55, 1885-1890.
7. Dragovic, D., Rosenstock, J. L., Wahl, S. J., Panagopoulos, G. et al., Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns. Clin. Nephrol. 2005, 6, 1-7.
8. Boyer, O., Moulder, J. K., Somers, M. J., Focal and segmental glomerulosclerosis in children: a longitudinal assessment. Pediatr. Nephrol. 2007, 22, 1159-1166.
9. Smith, J. M., Stablein, D. M., Munoz, R., Hebert, D. et al., Contributions of the transplant registry: the 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr. Transplant. 2007, 11, 366-373.
10. Korbet, S. M., Clinical picture and outcome of primary focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 1999, 14, 68-73.
11. Schwartz, M. M., Korbet, S. M., Rydell, J., Borok, R. et al., Primary focal segmental glomerular sclerosis in adults: prognostic value of histologic variants. Am. J. Kidney Dis. 1995, 25, 845-852.
12. Alexopoulos, E., Stangou, M., Papagianni, A., Pantzaki, A. et al., Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2000, 15, 1348-1356.
13. Thomas, D. B., Franceschini, N., Hogan, S. L., Ten Holder, S. et al., Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int. 2006, 69, 920-926.
14. Silverstein, D. M., Craver, R., Presenting features and short-term outcome according to pathologic variant in childhood primary focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 2007, 2, 700-707.
15. A Report of the International Study of Kidney Disease in Children, Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int. 1981, 20, 765-771.
16. Nakamura, T., Ushiyama, C., Suzuki, S., Hara, M. et al., The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. Am. J. Nephrol. 2000, 20, 175-179.
17. Woroniecki, R. P., Shatat, I. F., Supe, K., Du, Z. et al., Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood. Am. J. Nephrol. 2008, 28, 83-90.
18. Bennett, M. R., Ravipati, N., Ross, G., Nguyen, M. T. et al., Using proteomics to identify preprocedural risk factors for contrast induced nephropathy. Proteomics Clin. Appl. 2008, 2, 1058-1064.
19. Nguyen, M. T., Ross, G. F., Dent, C. L., Devarajan, P., Early prediction of acute renal injury using urinary proteomics. Am. J. Nephrol. 2005, 25, 318-326.
20. Parikh, C. R., Jani, A., Mishra, J., Ma, Q. et al., Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am. J. Transplant. 2006, 6, 1639-1645.
21. Hinze, C. H., Suzuki, M., Klein-Gitelman, M., Passo, M. H. et al., Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009, 60, 2772-2781.
22. Stangou, M., Alexopoulos, E., Papagianni, A., Pantzaki, A. et al., Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy. Nephrology (Carlton) 2009, 14, 613-620.
23. Magistroni, R., Ligabue, G., Lupo, V., Furci, L. et al., Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin. Nephrol. Dial. Transplant. 2009, 24, 1672-1681.
24. Khurana, M., Traum, A. Z., Aivado, M., Wells, M. P. et al., Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr. Nephrol. 2006, 21, 1257-1265.
25. Woroniecki, R. P., Orlova, T. N., Mendelev, N., Shatat, I. F. et al., Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Am. J. Nephrol. 2006, 26, 258-267.
26. Candiano, G., Musante, L., Bruschi, M., Petretto, A. et al., Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J. Am. Soc. Nephrol. 2006, 17, 3139-3148.
27. Schwartz, G. J., Munoz, A., Schneider, M. F., Mak, R. H. et al., New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. 2009, 20, 629-637.
28. Eknoyan, G., Levin, N. W., K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002, 39, S1-S266.
29. Eismann, T., Huber, N., Shin, T., Kuboki, S. et al., Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, G266-G274.
30. Ishioka, N., Takahashi, N., Putnam, F. W., Amino acid sequence of human plasma alpha 1B-glycoprotein: homology to the immunoglobulin supergene family. Proc. Natl. Acad. Sci. USA 1986, 83, 2363-2367.
31. Musante, L., Candiano, G., Petretto, A., Bruschi, M. et al., Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J. Am. Soc. Nephrol. 2007, 18, 799-810.
32. Afkarian, M., Bhasin, M., Dillon, S. T., Guerrero, M. C. et al., Optimizing a proteomics platform for urine biomarker discovery. Mol. Cell. Proteomics 2010, 9, 2195-2204.
33. Havanapan, P. O., Thongboonkerd, V., Are protease inhibitors required for gel-based proteomics of kidney and urine? J. Proteome Res. 2009, 8, 3109-3117.